InsidersTradesSigma
Follow the ラクオリア創薬株式会社 stock price and the full insider trade history of the company, a listed equity based in Japan. Shares trade on JP JP, under the supervision of EDINET (Japan FSA). Operating in the Health Care sector, ラクオリア創薬株式会社 has logged 9 insider filings. Market capitalisation: €12.5bn. The latest transaction was filed on 29 January 2026 (Holding update). Among the most active insiders: HK inno.N Corporation. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
9 of 9 declarations
Rakuaria Pharmaceutical Co., Ltd. is a company focused on the research and development of new drugs. It specializes in innovative treatments in the healthcare and pharmaceutical sector.